2roz
From Proteopedia
m (Protected "2roz" [edit=sysop:move=sysop]) |
|||
Line 8: | Line 8: | ||
==About this Structure== | ==About this Structure== | ||
- | [[2roz]] is a 2 chain structure | + | [[2roz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2ROZ OCA]. |
==See Also== | ==See Also== |
Revision as of 14:32, 20 October 2012
Contents |
Structure of the C-terminal PID Domain of Fe65L1 Complexed with the Cytoplasmic Tail of APP Reveals a Novel Peptide Binding Mode
Template:ABSTRACT PUBMED 18650440
About this Structure
2roz is a 2 chain structure with sequence from Mus musculus. Full experimental information is available from OCA.
See Also
Reference
- Li H, Koshiba S, Hayashi F, Tochio N, Tomizawa T, Kasai T, Yabuki T, Motoda Y, Harada T, Watanabe S, Inoue M, Hayashizaki Y, Tanaka A, Kigawa T, Yokoyama S. Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode. J Biol Chem. 2008 Oct 3;283(40):27165-78. Epub 2008 Jul 23. PMID:18650440 doi:10.1074/jbc.M803892200
- Gardberg AS, Dice LT, Ou S, Rich RL, Helmbrecht E, Ko J, Wetzel R, Myszka DG, Patterson PH, Dealwis C. Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15659-64. Epub 2007 Sep 25. PMID:17895381
Categories: Mus musculus | Harada, T. | Inoue, M. | Kigawa, T. | Koshiba, S. | Li, H. | RSGI, RIKEN Structural Genomics/Proteomics Initiative. | Tochio, N. | Watanabe, S. | Yokoyama, S. | Amyloid | Amyloid precursor protein | Apoptosis | Cell adhesion | Coated pit | Endocytosis | Fe65l1 | Glycoprotein | Heparin-binding | Iron | Membrane | Metal-binding | National project on protein structural and functional analyse | Notch signaling pathway | Nppsfa | Peptide binding protein | Phosphoprotein | Pid domain | Protease inhibitor | Riken structural genomics/proteomics initiative | Rsgi | Serine protease inhibitor | Structural genomic | Transmembrane